Vonorasan fumarate injection2
Phase 2Small molecule
Vonorasan fumarate injection2 is one of 25 small molecule programs targeting Peptic ulcer. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
24
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
28 competitors in Peptic Ulcer
#DrugCompanyPhaseTrials
1Prevacid
TakedaApproved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Bayer Aspirin
BayerApproved
Protonix
WWyeth-Lederle Vaccines
Approved
Dexilant
TakedaApproved
Cytotec
PfizerApproved
Takecab
PPhathom Pharmaceuticals, Inc.
Approved
Aciphex
Akero TherapeuticsApproved
Advil
KKenvue Brands
Approved
Rayos
RRoxane Laboratories
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details